Indian Pharma's future success depends on stringent quality control measures
Healthcare Radius|September 2022
Spurious drugs have become a serious issue worldwide, especially in India. According to USTR estimates nearly 20 percent of the drugs sold in India are counterfeit. Learn the steps that India must take to battle this menace and thus protect its image in the global pharmaceutical market
MS. ARUSHI JAIN
Indian Pharma's future success depends on stringent quality control measures

India has always been in the eye of the storm when it comes to the country's mounting spurious medicine problem. Even the US Trade Representative (USTR) has scrutinized Indian pharmaceutical companies over this issue since according to its report, approximately 20 percent of all drugs on sale in our market are counterfeit. And this is the kind of study that can adversely affect India's budding market and reputation, even as it ranks third in the world in terms of volume. India fulfills over 20 percent of the global demand for generic drugs, which is no surprise because we have over 10,500 manufacturing units and 3,000 firms across the country.

But the fact remains that if the industry does not invest correctly in the short term, India may fall behind in the race due to a sheer lack of quality products. To regain our status in the world pharma rankings, the Indian industry will have to take certain measures such as encouraging innovation through augmented spending on R&D, making marketing companies also accountable for product quality, and implementing more stringent quality control (QC).

Following are some more factors implementing which can directly result in improving the quality of Indian drugs and ensuring they are of the best quality going forward:

API quality check

This story is from the September 2022 edition of Healthcare Radius.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the September 2022 edition of Healthcare Radius.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

MORE STORIES FROM HEALTHCARE RADIUSView All
Entod opens R&D center in Navi Mumbai
Healthcare Radius

Entod opens R&D center in Navi Mumbai

ENTOD Pharmaceuticals inaugurates a new R&D center in Navi Mumbai, focusing on innovative pharmaceutical solutions and global leadership.

time-read
1 min  |
March 2024
DEDICATED ECMO UNITS: A POST-COVID IMPERATIVE
Healthcare Radius

DEDICATED ECMO UNITS: A POST-COVID IMPERATIVE

In the post-Covid world, the necessity of dedicated ECMO units have become paramount for managing critical cases efficiently, says the author.

time-read
3 mins  |
March 2024
HOPE AMIDST HESITATION?
Healthcare Radius

HOPE AMIDST HESITATION?

The Union Finance Minister Nirmala Sitharaman's Budget 2024-25 elicited a mixed response from healthcare sub-segments.

time-read
3 mins  |
March 2024
THE WONDERS OF WEARABLES Discover how wearables can offer a new hope to migraine patients in India.
Healthcare Radius

THE WONDERS OF WEARABLES Discover how wearables can offer a new hope to migraine patients in India.

Digital therapeutics (Dtx) is an emerging concept for therapeutic approaches in healthcare system.

time-read
2 mins  |
March 2024
ONLINE HEALTHCARE CONSULTATIONS: A TRANSFORMATION UNFOLDING
Healthcare Radius

ONLINE HEALTHCARE CONSULTATIONS: A TRANSFORMATION UNFOLDING

Discover how online consultations are transforming India’s healthcare landscape with the use of advanced technologies.

time-read
9 mins  |
March 2024
DRUG-RESISTANT TUBERCULOSIS: A CHALLENGE IN THE LAST LAP?
Healthcare Radius

DRUG-RESISTANT TUBERCULOSIS: A CHALLENGE IN THE LAST LAP?

India aims to eliminate tuberculosis by 2025, but drug-resistant strains pose a formidable challenge. Explore healthcare leaders’ views and potential solution approaches they offer—in this report.

time-read
10+ mins  |
March 2024
Meghalaya Cancer Conclave 2024 discusses cancer care in the state
Healthcare Radius

Meghalaya Cancer Conclave 2024 discusses cancer care in the state

Led by Dr Mazel Ampareen Lyngdoh, conclave focuses on critical cancer care issues.

time-read
1 min  |
March 2024
Woman with atrial septal defect saved at Medica
Healthcare Radius

Woman with atrial septal defect saved at Medica

A middle-aged woman from West Bengal suffering from Atrial Septal Defect ASD) successfully undergoes a complex procedure at Medica Hospital.

time-read
1 min  |
March 2024
Breastfeeding education initiative launched
Healthcare Radius

Breastfeeding education initiative launched

RISHTA 2024: An initiative by BSV and FOGSI to enhance breastfeeding education in India.

time-read
1 min  |
March 2024
5-kg fibroid removed with minimally invasive myomectomy
Healthcare Radius

5-kg fibroid removed with minimally invasive myomectomy

Doctors at Sahyadri Hospitals in Pune removed a 5-kg fibroid from a 35-year-old woman using a minimally invasive myomectomy, typically used in cesarean sections.

time-read
1 min  |
March 2024